Latest Articles
Activist pushes for menstrual leave and support at work - Primedia Plus
Activist pushes for menstrual leave and support at work Primedia Plus
Published: Sept. 3, 2025, 11:10 a.m.
'An absolute tragedy' - Funeral details announced for woman who died in bee sting accident - Offaly Express
'An absolute tragedy' - Funeral details announced for woman who died in bee sting accident Offaly Express
Published: Sept. 3, 2025, 10:54 a.m.
10 of the most promising EU-funded DeepTech startups - EU-Startups
10 of the most promising EU-funded DeepTech startups EU-Startups
Published: Sept. 3, 2025, 7 a.m.
'Her life's on hold' - young North Yorkshire woman in health crisis plea - The York Press
'Her life's on hold' - young North Yorkshire woman in health crisis plea The York Press
Published: Sept. 3, 2025, 3 a.m.
Molecule Shows Promise for MASH, Endometriosis, and Other Chronic Diseases | Newswise - Newswise
Molecule Shows Promise for MASH, Endometriosis, and Other Chronic Diseases | Newswise Newswise
Published: Sept. 2, 2025, 11:05 p.m.
Molecule Shows Promise for MASH, Endometriosis, and Other Chronic Diseases - Yale School of Medicine
Molecule Shows Promise for MASH, Endometriosis, and Other Chronic Diseases Yale School of Medicine
Published: Sept. 2, 2025, 12:57 p.m.
Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 as Demand for Hormone Therapy Accelerates – SNS Insider - SINA HONG KONG LIMITED
Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 as Demand for Hormone Therapy Accelerates – SNS Insider SINA HONG KONG LIMITED
Published: Sept. 2, 2025, 11:40 a.m.
Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 - GlobeNewswire
Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 GlobeNewswire
Published: Sept. 2, 2025, 10:32 a.m.
Nail polish product used by millions every week has been BANNED over health concerns - Daily Mail
Nail polish product used by millions every week has been BANNED over health concerns Daily Mail
Published: Sept. 2, 2025, 10:02 a.m.
XPR1: Emerging Prognostic Marker in Endometrial Cancer - BIOENGINEER.ORG
XPR1: Emerging Prognostic Marker in Endometrial Cancer BIOENGINEER.ORG
Published: Sept. 2, 2025, 9:51 a.m.
Link copied to clipboard!